This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Visa Stock Still a Safe Bet for Investors Amid Likely DOJ Lawsuit?
by Zacks Equity Research
DOJ's investigation into V began after its failed Plaid acquisition attempt in 2021.
Why Visa (V) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Why Visa (V) Outpaced the Stock Market Today
by Zacks Equity Research
In the most recent trading session, Visa (V) closed at $288.63, indicating a +1.36% shift from the previous trading day.
Wall Street Analysts Think Visa (V) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Visa (V) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Visa (V) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Visa (V) closed the most recent trading day at $290.37, moving +1.05% from the previous trading session.
Visa Inc. (V) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Visa (V) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Affirm Stock Soars 72% in a Year: Is It the Right Time to Invest?
by Debasmita Chatterjee
Despite rising costs and stiff competition, AFRM's AI-driven platform is revolutionizing payments in the BNPL market. An extensive merchant network remains an added strength.
Visa and 1Link Team Up to Expand Digital Payments in Pakistan
by Zacks Equity Research
The scope for V in Pakistan is substantial, given the country's large unbanked population and growing need for digital payment solutions.
The Zacks Analyst Blog Highlights Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian
by Zacks Equity Research
Visa, AbbVie, Anheuser-Busch, Servotronics and United-Guardian are included in this Analyst Blog.
Visa (V) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Visa (V) settling at $285.34, representing a -0.09% change from its previous close.
Top Stock Reports for Visa, AbbVie & Anheuser-Busch
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Anheuser-Busch InBev SA/NV (BUD), as well as two micro-cap stocks Servotronics, Inc. (SVT) and United-Guardian, Inc. (UG).
Mastercard Up 11.6% YTD: Is It Worth Buying the Stock Right Now?
by Zubia Masood
MA benefits from rising payment volume and value-added services and solutions growth, coupled with the ongoing secular shift to digital payments.
Visa Stock Up Nearly 9% in a Month: Is Now the Right Time to Invest?
by Kaibalya Pravo Dey
V's investments in advancing cybersecurity and fraud prevention enhance its appeal to both consumers and merchants.
Bull of the Day: PayPal (PYPL)
by Andrew Rocco
Venmo growth, strong partnerships, and a cheap valuation are bullish catalysts for PayPal shares over the next 6-12 months.
Why the Market Dipped But Visa (V) Gained Today
by Zacks Equity Research
The latest trading day saw Visa (V) settling at $278.54, representing a +0.79% change from its previous close.
Visa Inc. (V) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Visa (V) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
MasterCard (MA) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MasterCard (MA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmEx Stock Rallies 37.2% YTD: Time to Buy, Sell or Hold?
by Zubia Masood
AXP continues to benefit from new card acquisitions, fee growth and improved net interest income.
Affirm Holdings Q4 Loss Narrows Y/Y, GMV Outlook Raised
by Zacks Equity Research
AFRM expects GMV of more than $33.5 billion in fiscal 2025.
3 Fintech Stocks to Buy: AFRM, UPST, PYPL
by Andrew Rocco
New economy fintech and payment stocks exhibit strong growth and bullish prospects. Affirm's bullish earnings report last night should bolster this market segment further into 2025.
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
by Zacks Equity Research
Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical are included in this Analyst Blog.
Visa (V) Stock Moves -0.57%: What You Should Know
by Zacks Equity Research
Visa (V) closed at $269.19 in the latest trading session, marking a -0.57% move from the prior day.
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and The Walt Disney Company (DIS), as well as two micro-cap stocks FitLife Brands, Inc. (FTLF) and Utah Medical Products, Inc. (UTMD).
Should You Invest in the Financial Select Sector SPDR ETF (XLF)?
by Zacks Equity Research
Sector ETF report for XLF
Visa to Enhance Digital Payments With New Advisory Service
by Zacks Equity Research
Continuous addition of such new value-added services helps V to stay in the leading position in the payments landscape.